Crisaborole
RxNorm 1865953
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1865953 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: crisaborole.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Crisaborole
(Atom ID: 8713673)
PTPrescribable
Designated preferred name (PT):
Crisaborole
(Atom ID: 9249775)
FNPrescribable
Full form of descriptor (FN):
Crisaborole (substance)
(Atom ID: 9249776)
PTPrescribable
Designated preferred name (PT):
Crisaborole-containing product
(Atom ID: 10800406)
FNPrescribable
Full form of descriptor (FN):
Product containing crisaborole (medicinal product)
(Atom ID: 10305680)
Patient Education
Crisaborole Topical
Crisaborole is used to treat eczema (atopic dermatitis; a skin condition which causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in adults and children 3 years of age and older. Crisaborole is in a class of medications called phosphodiesterase inhibitors. It works by blocking the action of certain natural substances in the body that cause inflammation.
[Learn More]
* Please review the disclaimer below.